All stock lists
Unlock the score
Bladex, Inc. (New York Stock Exchange:BLX)
PA · Delayed Price · Currency is USD
Financial Services · Banks - Regional
53.37-0.55 (-1.01%)
Market cap
$1.53B
Insider Score
Health Score
Analyst consensus
Listed since
Sep 24, 1992
Website
Insider Score
/ 100
BLX Insider Score
BLADEX, INC. has a live Insider Score.
Scored on 2 qualifying trades from 2 insiders in the last 90 days.
Financial Health Score
Sound
From BLX’s reported statements · Q2 2026 (trailing 12 months)
Profitability20 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $605.6M
- Net income
- $233.9M
- Net margin
- 38.6%
Leverage0 / 20
Heavily indebted for what it earns.
- Total debt
- $4.44B
- Cash
- $1.86B
- Net debt / EBITDA
- 10.92x
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $1.89B
- Current liabilities
- $275.3M
- Current ratio
- 6.86
Cash generation20 / 20
The business funds itself from operations.
- Operating cash flow
- $393.1M
- Free cash flow
- $391.4M
- FCF margin
- 64.6%
Dilution & runway19 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 37.6M
- Share growth (1y)
- 1.7%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
BLX Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 224.71 M | 83.10 M | 88.80 M | 209.03 M | 216.73 M | 202.11 M |
| Revenue Growth (YoY) | 3.68 % | -58.88 % | -53.27 % | -0.29 % | 4.37 % | -0.57 % |
| Cost of Revenue | 134.54 M | 4.70 M | 5.40 M | 132.74 M | 131.71 M | 129.38 M |
| Gross Profit | 90.18 M | 78.40 M | 83.40 M | 76.30 M | 85.02 M | 72.73 M |
| SG&A Expense | 27.30 M | 13.35 M | 15.90 M | 13.20 M | 12.38 M | 13.94 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 23.85 M | 22.00 M | 27.40 M | 21.33 M | 20.84 M | 21.00 M |
| Operating Income | 66.50 M | 56.40 M | 56.00 M | 54.97 M | 64.18 M | 51.73 M |
| Pretax Income | 66.50 M | 56.40 M | 56.00 M | 54.97 M | 64.18 M | 51.73 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 66.50 M | 56.40 M | 56.00 M | 54.97 M | 64.20 M | 51.73 M |
| EPS (Basic) | 1.77 | 1.31 | 1.50 | 1.48 | 1.73 | 1.40 |
| EPS (Diluted) | 1.77 | 1.31 | 1.50 | 1.48 | 1.73 | 1.40 |
| Shares Outstanding | 37.57 M | 43.05 M | 37.33 M | 37.23 M | 36.94 M | 36.94 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.